We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Devon Energy
DVN
$47.4B
| $5.42M | 0.01% |
573,040
-243,800
| -30% | -$2.57M |
|
627
ProPetro Holding
PUMP
$1.34B
| $5.4M | 0.01% |
1,330,842
-300,000
| -18% | -$1.63M |
|
628
Lincoln National
LNC
$8.93B
| $5.24M | 0.01% |
167,261
+33,400
| +25% | +$1.19M |
|
629
DXC Technology
DXC
$1.77B
| $5.23M | 0.01% |
293,178
+5,700
| +2% | +$104K |
|
630
FerroAtlántica
GSM
$772M
| $5.18M | 0.01% |
7,741,392
-6,100,000
| -44% | -$3.23M |
|
631
nCino
NCNO
$2.08B
| $5.18M | 0.01% |
+65,000
| New | +$5.19M |
|
|
NARI
632
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $5.18M | 0.01% |
75,000
-225,000
| -75% | -$14.5M |
|
633
JetBlue
JBLU
$2.34B
| $5.15M | 0.01% |
454,600
+285,000
| +168% | +$3.2M |
|
634
Outfront Media
OUT
$5.48B
| $5.09M | 0.01% |
355,591
-152,397
| -30% | -$2.28M |
|
635
Kearny Financial
KRNY
$604M
| $5.05M | 0.01% |
700,000
+400,000
| +133% | +$3.07M |
|
|
KALV
636
DELISTED
KalVista Pharmaceuticals
KALV
| $5.04M | 0.01% |
400,000
| – | – |
|
637
Fox Class B
FOX
$23.2B
| $4.98M | 0.01% |
178,154
-4,598
| -3% | -$122K |
|
638
Camden Property Trust
CPT
$11B
| $4.96M | 0.01% |
55,728
+41,947
| +304% | +$3.77M |
|
639
HBT Financial
HBT
$1.32B
| $4.96M | 0.01% |
441,883
| – | – |
|
640
Perrigo
PRGO
$1.74B
| $4.95M | 0.01% |
107,896
-100
| -0.1% | -$5.24K |
|
641
Alaska Air
ALK
$5.66B
| $4.95M | 0.01% |
135,000
-4,500
| -3% | -$169K |
|
642
Exelixis
EXEL
$12.9B
| $4.87M | 0.01% |
199,000
-200,000
| -50% | -$4.67M |
|
|
AIV
643
Aimco
AIV
$381M
| $4.84M | 0.01% |
1,077,985
-136,233
| -11% | -$660K |
|
644
PVH
PVH
$3.99B
| $4.83M | 0.01% |
80,900
-2,600
| -3% | -$143K |
|
645
Invesco
IVZ
$14B
| $4.76M | 0.01% |
417,269
-13,600
| -3% | -$144K |
|
|
JAMF
646
DELISTED
Jamf
JAMF
| $4.7M | 0.01% |
+125,000
| New | +$4.69M |
|
647
nVent Electric
NVT
$26.4B
| $4.69M | 0.01% |
265,286
-1,243,227
| -82% | -$23.3M |
|
648
Norwegian Cruise Line
NCLH
$8.89B
| $4.68M | 0.01% |
273,600
-10,000
| -4% | -$158K |
|
649
C.H. Robinson
CHRW
$17.1B
| $4.65M | 0.01% |
45,500
-109,900
| -71% | -$10.3M |
|
|
NBL
650
DELISTED
Noble Energy, Inc.
NBL
| $4.59M | 0.01% |
537,062
-3,660,140
| -87% | -$35.8M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.